Viking Fund Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $27.7M | Buy |
110,000
+20,000
| +22% | +$4.3M | 2.48% | 5 |
|
|
2026
Q1 | $19.6M | Buy |
90,000
+17,000
| +23% | +$3.77M | 2.01% | 10 |
|
|
2025
Q4 | $16.7M | Sell |
73,000
-4,000
| -5% | -$911K | 1.93% | 9 |
|
|
2025
Q3 | $17.8M | Hold |
77,000
| – | – | 2.15% | 8 |
|
|
2025
Q2 | $14.3M | Sell |
77,000
-13,000
| -14% | -$2.42M | 1.96% | 9 |
|
|
2025
Q1 | $18.9M | Sell |
90,000
-20,000
| -18% | -$3.89M | 2.72% | 5 |
|
|
2024
Q4 | $19.5M | Sell |
110,000
-16,000
| -13% | -$2.94M | 3.04% | 3 |
|
|
2024
Q3 | $24.9M | Sell |
126,000
-16,500
| -12% | -$3.08M | 4.04% | 2 |
|
|
2024
Q2 | $24.4M | Buy |
142,500
+9,250
| +7% | +$1.53M | 4.38% | 2 |
|
|
2024
Q1 | $24.3M | Sell |
133,250
-9,000
| -6% | -$1.55M | 4.39% | 2 |
|
|
2023
Q4 | $22M | Hold |
142,250
| – | – | 4.29% | 2 |
|
|
2023
Q3 | $21.2M | Buy |
142,250
+8,060
| +6% | +$1.18M | 4.27% | 2 |
|
|
2023
Q2 | $18.1M | Buy |
134,190
+6,190
| +5% | +$908K | 3.42% | 2 |
|
|
2023
Q1 | $20.4M | Buy |
128,000
+4,000
| +3% | +$612K | 3.93% | 2 |
|
|
2022
Q4 | $20M | Buy |
124,000
+3,000
| +2% | +$460K | 3.98% | 1 |
|
|
2022
Q3 | $16.2M | Buy |
121,000
+11,000
| +10% | +$1.58M | 3.83% | 1 |
|
|
2022
Q2 | $16.8M | Buy |
110,000
+4,000
| +4% | +$611K | 3.9% | 1 |
|
|
2022
Q1 | $17.2M | Hold |
106,000
| – | – | 3.91% | 1 |
|
|
2021
Q4 | $14.4M | Buy |
106,000
+2,000
| +2% | +$236K | 3.78% | 2 |
|
|
2021
Q3 | $11.2M | Buy |
104,000
+12,000
| +13% | +$1.37M | 3.25% | 3 |
|
|
2021
Q2 | $10.4M | Buy |
92,000
+2,000
| +2% | +$225K | 2.96% | 2 |
|
|
2021
Q1 | $9.74M | Buy |
90,000
+3,000
| +3% | +$321K | 2.91% | 3 |
|
|
2020
Q4 | $9.32M | Buy |
87,000
+12,000
| +16% | +$1.15M | 3% | 1 |
|
|
2020
Q3 | $6.57M | Hold |
75,000
| – | – | 2.44% | 8 |
|
|
2020
Q2 | $7.36M | Buy |
75,000
+5,000
| +7% | +$440K | 2.72% | 5 |
|
|
2020
Q1 | $5.33M | Buy |
70,000
+12,000
| +21% | +$1.02M | 2.35% | 8 |
|
|
2019
Q4 | $5.13M | Buy |
58,000
+10,000
| +21% | +$830K | 1.44% | 29 |
|
|
2019
Q3 | $3.63M | Buy |
48,000
+10,000
| +26% | +$686K | 1.04% | 42 |
|
|
2019
Q2 | $2.76M | Buy |
38,000
+26,000
| +217% | +$2.04M | 0.73% | 52 |
|
|
2019
Q1 | $967K | Buy |
12,000
+2,000
| +20% | +$164K | 0.24% | 86 |
|
|
2018
Q4 | $922K | Buy |
+10,000
| New | +$879K | 0.26% | 85 |
|
Other funds holding ABBV
Viking Fund Management's ABBV Position: Q2 2026 in Review
Viking Fund Management increased its AbbVie (ABBV) stake by 22% in Q2 2026, buying an estimated $4.3M and bringing the position to 110,000 shares worth $27.7M. The position accounts for 2.48% of the portfolio, ranked #5.
Viking Fund Management first reported a position in ABBV in Q4 2018 and has held it in 31 quarters since. 4,192 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Viking Fund Management held 110,000 shares of AbbVie worth $27.7M as of Q2 2026.
- Viking Fund Management bought 20,000 AbbVie shares in Q2 2026, an estimated $4.3M.
- AbbVie made up 2.48% of Viking Fund Management's portfolio in Q2 2026, its #5 holding.
- Viking Fund Management first reported a position in AbbVie in Q4 2018 and has held it in 31 quarters since.
- 4,192 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Viking Fund Management's 13F filing for Q2 2026, filed 13 Jul 2026.